Although Oct-4 has been detected in various carcinomas, including breast cancer [9], bladder cancer [10], prostate cancer [11] and lung adenocarcinoma [20], the precise role of this stem cell marker in maintaining the survival of cancer cells is unclear. This evidence concerns the gene POU5F1 and prostate cancer.